Press Releases - 2019-10-30

Date	Title	Company
30-Oct-2019	Worldwide Narcolepsy Drug Market Expected to grow exponentially with Key players- Teva Pharmaceutical, Novartis, Mylan	Wired Release
30-Oct-2019	Global Mildronate Dihydrate To Register A Stout Growth By 2020-2029 \| Size, Share & Growth	Wired Release
30-Oct-2019	Worldwide Virus Filtration Research to Reflect Steady Growth Rate by 2020-2029 \| Thermo Fisher, Sartorius AG, Lonza	Wired Release
30-Oct-2019	Hemostatic Agents Market Insight by Latest Technologies and In Depth Analysis 2029 \| Ethicon, Pfizer, C. R. Bard	Wired Release
30-Oct-2019	Worldwide Folate Market Size 2020 \| Key Drivers, End Users & Future Prospects 2029 \| Gnosis SPA, DSM, Merck	Wired Release
30-Oct-2019	Worldwide Cell Expansion Technologies Expanding Massively by 2020-2029 with Profiling Players Miltenyi Biotec, Life Technologies, Replicell	Wired Release
30-Oct-2019	Vaccine Adjuvants Market Soaring Demand from Healthcare Industry to increase Market Growth \| 2029	Wired Release
30-Oct-2019	Biopharmaceuticals Market Technological Advancement & Growth Analysis with Forecast to 2029 \| Roche, Amgen, AbbVie	Wired Release
30-Oct-2019	Depression Drugs Market to Garner Brimming Revenues by 2020-2029 \| Lundbeck, Allergan, GSK	Wired Release
30-Oct-2019	Navigating the Globalisation of Clinical Trials	Medidata
30-Oct-2019	Global Survey Finds CROs Undergoing Major Changes to Speed Clinical Trials	Veeva
30-Oct-2019	MultiTEP Platform-Based Epitope Vaccine Targeting the Phosphatase Activating Domain (PAD) of Tau Shows Clear Therapeutic Efficacy in PS19 Mice	Capo Therapeutics, Inc
30-Oct-2019	Sanifit announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint in slowing the progression of cardiovascular calcification in patients on hemodialysis Top line data to be presented at 2019 Scientific Sessions of American Heart Association	Sanifit
30-Oct-2019	New ImpactAir ISO-90 microbial air sampler	CHERWELL LABORATORIES
30-Oct-2019	Dupixent® (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis	Regeneron
30-Oct-2019	Anatomic Pathology Market Worth $44.4 Billion by 2024 - Exclusive Report by MarketsandMarkets™	MarketsandMarkets
30-Oct-2019	Junior account executive	Discovery PR
30-Oct-2019	SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor	B3C newswire
30-Oct-2019	ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2019 Financial Results	ANI Pharmaceuticals, Inc.
30-Oct-2019	Galmed Pharmaceuticals to Report Third Quarter 2019 Financial Results and Provide Business Update on Wednesday, November 6	Galmed Pharmaceuticals Ltd.